PRPO
HEALTHCAREPrecipio Inc
$29.98-2.39 (-7.38%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PRPO Today?
No stock-specific AI insight has been generated for PRPO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$6.29$33.63
$29.98
Fundamentals
Market Cap$54M
P/E Ratio—
EPS$-0.23
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume34K
Avg Volume (10D)—
Shares Outstanding1.8M
PRPO News
20 articles- Precipio Announces Q1-2026 Shareholder Update CallYahoo Finance·May 6, 2026
- Precipio, Inc. Q4 2025 Earnings Call SummaryMoby·Mar 31, 2026
- Precipio Announces Q4 and year-end 2025 Shareholder Update CallYahoo Finance·Mar 12, 2026
- Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 AssayYahoo Finance·Mar 10, 2026
- Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-YearYahoo Finance·Feb 25, 2026
- Precipio Takes Major Steps Toward a Clean Balance SheetYahoo Finance·Jan 15, 2026
- Top Stock Reports for AbbVie, Coca-Cola & ChevronYahoo Finance·Dec 24, 2025
- Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) MeetingYahoo Finance·Dec 5, 2025
- Precipio Identifies Unauthorized Access to Isolated Storage; No Operational ImpactYahoo Finance·Dec 4, 2025
- Precipio Stock Up Following Solid Q3 Earnings and Improved Cash FlowYahoo Finance·Nov 19, 2025
- Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...Yahoo Finance·Nov 18, 2025
- Precipio Announces its Q3-2025 Financial ResultsYahoo Finance·Nov 14, 2025
- Precipio Announces Q3-2025 Shareholder Update CallYahoo Finance·Nov 4, 2025
- The Zacks Analyst Blog Highlights HSBC, American Express, TotalEnergies, Armanino Foods of Distinction and PrecipioYahoo Finance·Sep 23, 2025
- Precipio Terminates Its ATMYahoo Finance·Sep 2, 2025
- Precipio Second Quarter 2025 Earnings: EPS: US$0.049 (vs US$0.83 loss in 2Q 2024)Yahoo Finance·Aug 15, 2025
- Precipio Announces its Q2-2025 Financial ResultsYahoo Finance·Aug 13, 2025
- Precipio Announces Q2-2025 Shareholder Update CallYahoo Finance·Jul 31, 2025
- Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As CashlessYahoo Finance·Jul 11, 2025
- Arena Group Holdings vs. Precipio: 2 New Top 100 Stocks to Buy. Precipio’s the Buy.Barchart·Jul 8, 2025
All 20 articles loaded
Price Data
Open$32.50
Previous Close$32.37
Day High$33.63
Day Low$31.96
52 Week High$33.63
52 Week Low$6.29
52-Week Range
$6.29$33.63
$29.98
Fundamentals
Market Cap$54M
P/E Ratio—
EPS$-0.23
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume34K
Avg Volume (10D)—
Shares Outstanding1.8M
About Precipio Inc
Precipio, Inc., a cancer diagnostic and reagent technology company, provides diagnostic products and services in the United States oncology market. The company is headquartered in New Haven, Connecticut.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—